Literature DB >> 21727914

Familial forms of diabetes insipidus: clinical and molecular characteristics.

Muriel Babey1, Peter Kopp, Gary L Robertson.   

Abstract

Over the past two decades, the genetic and molecular basis of familial forms of diabetes insipidus has been elucidated. Diabetes insipidus is a clinical syndrome characterized by the excretion of abnormally large volumes of diluted urine (polyuria) and increased fluid intake (polydipsia). The most common type of diabetes insipidus is caused by lack of the antidiuretic hormone arginine vasopressin (vasopressin), which is produced in the hypothalamus and secreted by the neurohypophysis. This type of diabetes insipidus is referred to here as neurohypophyseal diabetes insipidus. The syndrome can also result from resistance to the antidiuretic effects of vasopressin on the kidney, either at the level of the vasopressin 2 receptor or the aquaporin 2 water channel (which mediates the re-absorption of water from urine), and is referred to as renal or nephrogenic diabetes insipidus. Differentiation between these two types of diabetes insipidus and primary polydipsia can be difficult owing to the existence of partial as well as complete forms of vasopressin deficiency or resistance. Seven different familial forms of diabetes insipidus are known to exist. The clinical presentation, genetic basis and cellular mechanisms responsible for them vary considerably. This information has led to improved methods of differential diagnosis and could provide the basis of new forms of therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21727914     DOI: 10.1038/nrendo.2011.100

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  84 in total

Review 1.  The magnocellular neuronal phenotype: cell-specific gene expression in the hypothalamo-neurohypophysial system.

Authors:  H Gainer; M Yamashita; R L Fields; S B House; M Rusnak
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

Review 2.  Familial neurohypophyseal diabetes insipidus--an update.

Authors:  Jane H Christensen; Søren Rittig
Journal:  Semin Nephrol       Date:  2006-05       Impact factor: 5.299

3.  Decreased expression of AQP2 and AQP4 water channels and Na,K-ATPase in kidney collecting duct in AQP3 null mice.

Authors:  Soo Wan Kim; Veronika Gresz; Aleksandra Rojek; Weidong Wang; A S Verkman; Jørgen Frøkiaer; Søren Nielsen
Journal:  Biol Cell       Date:  2005-10       Impact factor: 4.458

4.  Nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Brian J Feldman; Stephen M Rosenthal; Gabriel A Vargas; Raymond G Fenwick; Eric A Huang; Mina Matsuda-Abedini; Robert H Lustig; Robert S Mathias; Anthony A Portale; Walter L Miller; Stephen E Gitelman
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

5.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons.

Authors:  Theron A Russell; Masafumi Ito; Mika Ito; Richard N Yu; Fred A Martinson; Jeffrey Weiss; J Larry Jameson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Eric Carpentier; Driss Rochdi; W van't Hoff; Billy Breton; Virginie Bernier; Michel Bouvier; Daniel G Bichet
Journal:  Nephron Physiol       Date:  2009-10-08

7.  Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct.

Authors:  S Sasaki; K Fushimi; H Saito; F Saito; S Uchida; K Ishibashi; M Kuwahara; T Ikeuchi; K Inui; K Nakajima
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2.

Authors:  B A Gabreëls; D F Swaab; D P de Kleijn; A Dean; N G Seidah; J W Van de Loo; W J Van de Ven; G J Martens; F W Van Leeuwen
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

9.  Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus.

Authors:  Nannette Marr; Daniel G Bichet; Susan Hoefs; Paul J M Savelkoul; Irene B M Konings; Fabrizio De Mattia; Michael P J Graat; Marie-Françoise Arthus; Michele Lonergan; T Mary Fujiwara; Nine V A M Knoers; Daniel Landau; William J Balfe; Alexander Oksche; Walter Rosenthal; Dominik Müller; Carel H Van Os; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  34 in total

Review 1.  Copeptin in the differential diagnosis of hypotonic polyuria.

Authors:  M Christ-Crain; W K Fenske
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

2.  GATA2 regulates body water homeostasis through maintaining aquaporin 2 expression in renal collecting ducts.

Authors:  Lei Yu; Takashi Moriguchi; Tomokazu Souma; Jun Takai; Hironori Satoh; Naoki Morito; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

3.  Comparative transcriptomic analysis reveals mechanisms of divergence in osmotic regulation of the turbot Scophthalmus maximus.

Authors:  Wenxiao Cui; Aijun Ma; Zhihui Huang; Xinan Wang; Zhifeng Liu; Dandan Xia; Shuangshuang Yang; Tingting Zhao
Journal:  Fish Physiol Biochem       Date:  2020-05-07       Impact factor: 2.794

4.  Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β.

Authors:  Chiara Gabbi; Xiaomu Kong; Hitoshi Suzuki; Hyun-Jin Kim; Min Gao; Xiao Jia; Hideo Ohnishi; Yoichi Ueta; Margaret Warner; Youfei Guan; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

5.  Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.

Authors:  Sei Sasaki; Motoko Chiga; Eriko Kikuchi; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

Review 6.  Cell biology of vasopressin-regulated aquaporin-2 trafficking.

Authors:  Hanne B Moeller; Robert A Fenton
Journal:  Pflugers Arch       Date:  2012-06-29       Impact factor: 3.657

7.  A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.

Authors:  Wiebke Kristin Fenske; Mirjam Christ-Crain; Anna Hörning; Jessica Simet; Gabor Szinnai; Martin Fassnacht; Jonas Rutishauser; Daniel G Bichet; Stefan Störk; Bruno Allolio
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

8.  A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.

Authors:  Marie Helene Schernthaner-Reiter; David Adams; Giampaolo Trivellin; Mary Scott Ramnitz; Margarita Raygada; Gretchen Golas; Fabio R Faucz; Ola Nilsson; Aikaterini A Nella; Kavitha Dileepan; Maya Lodish; Paul Lee; Cynthia Tifft; Thomas Markello; William Gahl; Constantine A Stratakis
Journal:  Eur J Pediatr       Date:  2016-01-21       Impact factor: 3.183

Review 9.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

10.  Deficiency of WFS1 leads to the impairment of AVP secretion under dehydration in male mice.

Authors:  Junki Kurimoto; Hiroshi Takagi; Takashi Miyata; Yuichi Hodai; Yohei Kawaguchi; Daisuke Hagiwara; Hidetaka Suga; Tomoko Kobayashi; Mariko Sugiyama; Takeshi Onoue; Yoshihiro Ito; Shintaro Iwama; Ryoichi Banno; Katsuya Tanabe; Yukio Tanizawa; Hiroshi Arima
Journal:  Pituitary       Date:  2021-03-05       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.